Drugs

An international team led in part by the Garvan Institute of Medical Research has found a possible explanation for why certain cancer patients who undergo checkpoint inhibitor immunotherapy face heightened risks of common infections. Detailed in the publication Immunity, these […]

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) urges remaining marketing authorization holders to be ready for the upcoming packaging and labeling regulations. Despite most of the industry demonstrating a high level of preparedness, this final call serves as

While the central authorities are introducing new strategies and support to boost the medical devices industry in the nation, certain factors are impeding its progress, according to industry insiders. In early November, the Department of Pharmaceuticals (DoP), under the Union

The Kerala drug control department is set to completely embrace digital technology, with all remaining service areas moving online shortly, as reported by sources. This transition is part of the health department’s initiative to seamlessly integrate digital solutions into the

Karnataka is actively addressing the escalating threat posed by counterfeit drugs to protect public welfare. The state is implementing a range of approaches designed to assure that only premium quality and efficacious medications are available to patients. This involves rigorous

The Directorate General of Trade Remedies (DGTR), operating under the Ministry of Commerce and Industry, has concluded its anti-dumping probe into the importation of mono ethylene glycol (MEG) from Kuwait, Saudi Arabia, and the United States without imposing any measures.

Recognizing the opportunities to integrate the Ayush sector with insurance benefits, the Kerala branch of the National Ayush Mission has established a dedicated division to promote insurance coverage within the state’s Ayush sector. This initiative was sparked following a recent

Entod Pharmaceuticals, a prominent player in the nation’s eye care industry, has demonstrated impressive market growth, reinforcing its strong stance in both ophthalmology and ENT (ear, nose, throat) treatment sectors. According to the most recent market insights from September 2024

Quadria Capital has partnered with HealthQuad and PwC India to unveil a pivotal report entitled “Financing the Climate-Health Frontier: Emerging Opportunities.” This extensive analysis underscores the vital necessity for increased funding in climate-resilient healthcare infrastructure to mitigate the severe health

The NIHR has announced a £25 million funding initiative designed to propel the health and social care system towards achieving net zero. This funding opportunity, representing a multi-programme commitment to climate health and sustainability by the NIHR, seeks to lower